Venous Thromboembolism (VTE) Archives

Anticoagulation or antiplatelet as secondary prevention for cancer-related strokes?

Presented By

Dr Moritz Kielkopf, University of Bern, Switzerland

Conference

EAN 2024

Type

News article

25 July 2024 10:26

Novel risk assessment model acts on increasing hospital-acquired venous thromboembolism rates among children

Presented By

Dr Julie Jaffray, Rady Children’s Hospital-San Diego, CA, USA

Conference

ASH 2023

Type

Peer-reviewed article

7 February 2024 14:55

Head-to-head: Surgical embolectomy versus ultrasound-assisted thrombolysis in high-risk pulmonary embolism

Presented By

Dr Stefan Stortecky, University of Bern, Switzerland

Trial

Phase 2, SPECIAL

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:26

The optimal duration of anticoagulation therapy in cancer patients with DVT

Presented By

Dr Yugo Yamashita, Kyoto University, Japan

Trial

ONCO DVT

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:03

Hormone therapy for gender dysphoria associated with increased CV risk

Presented By

Dr Ibrahim Ahmed, Mercy Catholic Medical Center, PA, USA

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:24

New analysis assesses the safety of tofacitinib regarding extended MACE

Presented By

Prof. Maya Buch, University of Manchester, United Kingdom

Trial

ORAL Surveillance

Conference

ACR 2022

Type

News article

1 December 2022 14:18

Psoriasis treatment: no elevation of MACE and VTE on deucravacitinib

Presented By

Prof. Mark Lebwohl , Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 3, POETYK PSO-1, POETYK PSO-2

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 09:50

VTE in global registry data more common in JAK inhibitor-treated RA patients

Presented By

Prof. Adeline Ruyssen-Witrand, Toulouse University Hospital, France

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 14:52

Milvexian phase 2 data supports safety and efficacy for VTE prevention after total knee replacement

Presented By

Prof. Jeffrey Weitz, McMaster University, Canada

Trial

Phase 2, AXIOMATIC-TKR

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 13:54

AHA 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AHA 2021

30 November 2021 23:20

Increased risk of cerebral venous thrombosis in COVID-19

Presented By

Dr Sajid Hameed , Aga Khan University, Pakistan

Conference

IHC 2021

Type

Peer-reviewed article

8 November 2021 13:26

Rivaroxaban improves clinical outcomes in discharged COVID-19 patients

Presented By

Prof. Eduardo Ramacciotti, Santa Casa School of Medicine, Brasil

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:40

COVID-19: Thromboembolic risk reduction with therapeutic heparin dosing

Presented By

Prof. Alex Spyropoulos, Northwell Health, USA

Trial

Phase 3, HEP-COVID

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:34

Haemostatic abnormalities are associated with mortality in COVID-19

Presented By

Dr Yu Hu, Wuhan Union Hospital, China

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 15:07

PCSK9 inhibition as primary prevention for VTE: Is it LDL or Lp(a)?

Presented By

Dr Nicholas A. Marston, Women’s Hospital, Boston, USA

Trial

FOURIER, ODYSSEY OUTCOMES, JUPITER

Journal

Physician’s Weekly

Conference

American Heart Association Scientific Sessions 2020

13 April 2021 18:38

PAD: Rivaroxaban reduces VTE risk after revascularisation

Presented By

Dr Connie Hess; Prof. Judith Hsia

Trial

VOYAGER PAD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:45

Similar outcomes sPESI and HESTIA for pulmonary embolism triage

Presented By

Prof. Pierre-Marie Roy, University Hospital of Angers, France

Trial

HOME-PE trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:16

Surgical bleeding risk most important determinant of bleeding outcomes

Presented By

Dr Kira MacDougall, Staten Island University Hospital, USA

Trial

PAUSE

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 16:27

Similar bleeding rates in patients with VTE and AF treated with DOACs

Presented By

Dr Farès Moustafa, CHU Clermont Ferrand, France

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 16:21

Residual pulmonary obstruction may predict risk of VTE recurrence

Presented By

Dr Robin Chaux, University Hospital St. Etienne, France

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:50

Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis

Presented By

Dr Florian Moik, Medical university of Vienna, Austria

Trial

Cohort study

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:44

Crosstalk between inflammation and coagulation in severe COVID-19 infections

Presented By

Prof. Roberta Gualtierotti, University of Milan, Italy

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:21

COVID-19 associated with higher VTE rates relative to influenza

Presented By

Dr Milou Stals, Leiden University Medical Centre, the Netherlands

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:18

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Trial

Cohort study

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:15

COVID-19 not associated with heightened VTE risk after discharge

Presented By

Dr Matthias Engelen, University Hospital Leuven, Belgium

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 15:09

Lower embryopathy risk with DOAC versus VKA during pregnancy

Presented By

Dr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:53

Higher thrombotic risk in NSCLC patient with ALK rearrangement

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:41

Apixaban offers new perspective for cancer patients in need of anticoagulation

Presented By

Prof. G. Agnelli, University of Perugia, Italy

Trial

Phase 3, CARAVAGGIO

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:13

Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery

Presented By

Prof. N. Rosencher, Paris Center University Hospital, France

Trial

PRONOMOS

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:07

Higher mortality risk with tramadol versus NSAIDs for osteoarthritis patients

Presented By

Lingyi Li, University of British Columbia, Canada

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:37

Rivaroxaban is safe and effective for paediatric venous thromboembolism

Presented By

Prof. Guy Young, Children's Hospital Los Angeles, USA

Trial

Phase 3, EINSTEIN-Jr

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 20:19

Aspirin plus DOAC is not better than a DOAC alone

Presented By

Prof. Jordan Schaefer, University of Michigan, USA

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 19:23

Apixaban is safe and effective in real-world setting for treatment of venous thromboembolism

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 12:17

Early discharge and home treatment feasible for low-risk pulmonary embolism patients

Trial

HoT-PE

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 11:01